{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:01:42Z","timestamp":1759777302414,"version":"3.44.0"},"reference-count":23,"publisher":"The Pediatric Pharmacy Association","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"abstract":"<jats:p>Although a high vancomycin serum concentration is known to be associated with nephrotoxicity, its association with ototoxicity is not well known. The purpose of our study was to examine the latter association in pediatric patients, especially in cases of accidental overdose. Pediatric patients who received vancomycin at our facility between March 2010 and December 2015 with a serum trough concentration &gt; 30 mg\/L were enrolled. Age, sex, neonatal hearing screening results, estimated peak vancomycin serum concentration, duration of drug exposure, renal function, and hearing test results were collected. The estimated duration of concentrations above 30 or 80 mg\/L were simulated with the Sawchuk-Zaske method. We defined a \u201chigh concentration\u201d and \u201ctoxic concentration\u201d of vancomycin as 30 to 80 mg\/L and &gt; 80 mg\/L, respectively. Ototoxicity was assessed based on the auditory brain stem response. We identified 4 females and 2 males with normal hearing at birth. Four of the 6 patients were \u2264 3 months old. All the patients reached an estimated peak serum concentration of &gt; 80 mg\/L, and 5 exceeded 150 mg\/L. The estimated duration of exposure to a high concentration and toxic concentration of vancomycin was 15 to 62 hours and 8 to 43 hours, respectively. All the patients experienced transient renal dysfunction. Although transient ototoxicity was found in 1 patient, prolonged ototoxicity was not observed in any of the patients. All the patients had received an accidental overdose of vancomycin. Prolonged hearing loss due to a high vancomycin serum concentration was not found in any of the subjects in the present report.<\/jats:p>","DOI":"10.5863\/1551-6776-24.5.450","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T20:38:50Z","timestamp":1570480730000},"page":"450-455","source":"Crossref","is-referenced-by-count":9,"title":["Ototoxicity and Nephrotoxicity With Elevated Serum Concentrations Following Vancomycin Overdose: A Retrospective Case Series"],"prefix":"10.5863","volume":"24","author":[{"given":"Kazuhiro","family":"Uda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Suwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hataya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuho","family":"Horikoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"2","key":"i1551-6776-24-5-450-b1","series-title":"J Antimicrob Chemother","first-page":"235","article-title":"A prospective study of adverse reactions associated with vancomycin therapy","volume":"16","year":"1985","unstructured":"Sorrell\n              TC\n            , CollignonPJ.\n          A prospective study of adverse reactions associated with vancomycin therapy. J Antimicrob Chemother. 1985;16(2):235\u2013241."},{"issue":"12","key":"i1551-6776-24-5-450-b2","series-title":"Ann Pharmacother","first-page":"1555","article-title":"Factors associated with acute kidney injury in children receiving vancomycin","volume":"48","year":"2014","unstructured":"Sinclair\n              EA\n            , YenokyanG, McMunnA, \n          et al. Factors associated with acute kidney injury in children receiving vancomycin. Ann Pharmacother. 2014;48(12):1555\u20131562."},{"issue":"1","key":"i1551-6776-24-5-450-b3","series-title":"Infect Dis Ther","first-page":"37","article-title":"Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children","volume":"2","year":"2013","unstructured":"Ragab\n              AR\n            , Al-MazrouaMK, Al-HaronyMA.\n          Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children. Infect Dis Ther. 2013;2(1):37\u201346."},{"issue":"8","key":"i1551-6776-24-5-450-b4","series-title":"Clin Infect Dis","first-page":"975","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets","volume":"52","year":"2011","unstructured":"Kullar\n              R\n            , DavisSL, LevineDP, \n          et al. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Clin Infect Dis. 2011;52(8):975\u2013981."},{"issue":"3","key":"i1551-6776-24-5-450-b5","series-title":"Pharmacotherapy","first-page":"337","article-title":"Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study","volume":"35","year":"2015","unstructured":"Matson\n              KL\n            , ShafferCL, BeckGL, \n          et al. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study. Pharmacotherapy. 2015;35(3):337\u2013343."},{"issue":"2","key":"i1551-6776-24-5-450-b6","series-title":"Antimicrob Agents Chemother","first-page":"483","article-title":"Vancomycin ototoxicity: a reevaluation in an era of increasing doses","volume":"53","year":"2009","unstructured":"Forouzesh\n              A\n            , MoisePA, SakoulasG.\n          Vancomycin ototoxicity: a reevaluation in an era of increasing doses. Antimicrob Agents Chemother. 2009;53(2):483\u2013486."},{"issue":"7","key":"i1551-6776-24-5-450-b7","series-title":"Proc Staff Meet Mayo Clin","first-page":"172","article-title":"Antibiotic therapy of bacterial endocarditis. VII. Vancomycin for acute micrococcal endocarditis; preliminary report","volume":"33","year":"1958","unstructured":"Geraci\n              JE\n            , HeilmanFR, NicholsDR, WellmanWE.\n          Antibiotic therapy of bacterial endocarditis. VII. Vancomycin for acute micrococcal endocarditis; preliminary report. Proc Staff Meet Mayo Clin. 1958;33(7):172\u2013181."},{"issue":"4","key":"i1551-6776-24-5-450-b8","series-title":"Ann Intern Med","first-page":"458","article-title":"Vancomycin ototoxicity in patient with normal renal function","volume":"95","year":"1981","unstructured":"Traber\n              PG\n            , LevineDP.\n          Vancomycin ototoxicity in patient with normal renal function. Ann Intern Med. 1981;95(4):458\u2013460."},{"issue":"8","key":"i1551-6776-24-5-450-b9","series-title":"Am J Perinatol","first-page":"433","article-title":"Large vancomycin overdose in two premature infants with minimal toxicity","volume":"21","year":"2004","unstructured":"Miner\n              LJ\n            , FaixRG.\n          Large vancomycin overdose in two premature infants with minimal toxicity. Am J Perinatol. 2004;21(8):433\u2013438."},{"issue":"8","key":"i1551-6776-24-5-450-b10","series-title":"Pediatr Infect Dis J","first-page":"744","article-title":"Accidental overdose of vancomycin in preterm twins","volume":"18","year":"1999","unstructured":"Muller\n              D\n            , HufnagelM, SuttorpM.\n          Accidental overdose of vancomycin in preterm twins. Pediatr Infect Dis J1999;18(8):744\u2013745."},{"issue":"3","key":"i1551-6776-24-5-450-b11","series-title":"Clin Pharmacol Ther","first-page":"362","article-title":"Kinetic model for gentamicin dosing with the use of individual patient parameters","volume":"21","year":"1977","unstructured":"Sawchuk\n              RJ\n            , ZaskeDE, CipolleRJ, \n          et al. Kinetic model for gentamicin dosing with the use of individual patient parameters. Clin Pharmacol Ther. 1977;21(3):362\u2013369."},{"issue":"15","key":"i1551-6776-24-5-450-b12","series-title":"JAMA","first-page":"1701","article-title":"Newborn hearing screening vs later hearing screening and developmental outcomes in children with permanent childhood hearing impairment","volume":"304","year":"2010","unstructured":"Korver\n              AM\n            , KoningsS, DekkerFW, \n          et al. Newborn hearing screening vs later hearing screening and developmental outcomes in children with permanent childhood hearing impairment. JAMA. 2010;304(15):1701\u20131708."},{"issue":"5","key":"i1551-6776-24-5-450-b13","series-title":"Am J Kidney Dis","first-page":"673","article-title":"Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury","volume":"61","year":"2013","unstructured":"James\n              M\n            , BouchardJ, HoJ, \n          et al. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61(5):673\u2013685."},{"issue":"2","key":"i1551-6776-24-5-450-b14","series-title":"Pediatrics","first-page":"e463","article-title":"Neonatal acute kidney injury","volume":"136","year":"2015","unstructured":"Selewski\n              DT\n            , CharltonJR, JettonJG, \n          et al. Neonatal acute kidney injury. Pediatrics. 2015;136(2):e463\u2013e473."},{"key":"i1551-6776-24-5-450-b15","series-title":"Ann N Y Acad Sci","first-page":"1","article-title":"Global problem of drug-induced hearing loss","volume":"884","year":"1999","unstructured":"Arslan\n              E\n            , OrzanE, SantarelliR.\n          Global problem of drug-induced hearing loss. Ann N Y Acad Sci. 1999;884:1\u201314."},{"issue":"2","key":"i1551-6776-24-5-450-b16","series-title":"J Toxicol Clin Toxicol","first-page":"285","article-title":"Exchange transfusion and multidose activated charcoal following vancomycin overdose","volume":"30","year":"1992","unstructured":"Burkhart\n              KK\n            , MetcalfS, ShurnasE, \n          et al. Exchange transfusion and multidose activated charcoal following vancomycin overdose. J Toxicol Clin Toxicol. 1992;30(2):285\u2013294."},{"issue":"1","key":"i1551-6776-24-5-450-b17","series-title":"J Perinatol","first-page":"3","article-title":"Ototoxicity in preterm infants: effects of genetics, aminoglycosides, and loud environmental noise","volume":"33","year":"2013","unstructured":"Zimmerman\n              E\n            , LahavA.\n          Ototoxicity in preterm infants: effects of genetics, aminoglycosides, and loud environmental noise. J Perinatol. 2013;33(1):3\u20138."},{"issue":"5","key":"i1551-6776-24-5-450-b18","series-title":"ORL J Otorhinolaryngol Relat Spec","first-page":"273","article-title":"Ototoxicity of vancomycin: an experimental study in guinea pigs","volume":"53","year":"1991","unstructured":"Lutz\n              H\n            , LenarzT, WeidauerH, \n          et al. Ototoxicity of vancomycin: an experimental study in guinea pigs. ORL J Otorhinolaryngol Relat Spec. 1991;53(5):273\u2013278."},{"issue":"6","key":"i1551-6776-24-5-450-b19","series-title":"Antimicrob Agents Chemother","first-page":"791","article-title":"Vancomycin- and erythromycin-induced hearing loss in humans","volume":"33","year":"1989","unstructured":"Brummett\n              RE\n            , FoxKE.\n          Vancomycin- and erythromycin-induced hearing loss in humans. Antimicrob Agents Chemother. 1989;33(6):791\u2013796."},{"issue":"1","key":"i1551-6776-24-5-450-b20","series-title":"Arch Otolaryngol Head Neck Surg","first-page":"61","article-title":"Augmented gentamicin ototoxicity induced by vancomycin in guinea pigs","volume":"116","year":"1990","unstructured":"Brummett\n              RE\n            , FoxKE, JacobsF, \n          et al. Augmented gentamicin ototoxicity induced by vancomycin in guinea pigs. Arch Otolaryngol Head Neck Surg. 1990;116(1):61\u201364."},{"issue":"5","key":"i1551-6776-24-5-450-b21","series-title":"Med Toxicol Adverse Drug Exp","first-page":"376","article-title":"Vancomycin ototoxicity and nephrotoxicity. A review","volume":"3","year":"1988","unstructured":"Bailie\n              GR\n            , NealD.\n          Vancomycin ototoxicity and nephrotoxicity. A review. Med Toxicol Adverse Drug Exp. 1988;3(5):376\u2013386."},{"issue":"1","key":"i1551-6776-24-5-450-b22","series-title":"J Pediatr","first-page":"41","article-title":"Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss","volume":"142","year":"2003","unstructured":"de Hoog\n              M\n            , van ZantenBA, HopWC, \n          et al. Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss. J Pediatr. 2003;142(1):41\u201346."},{"issue":"7","key":"i1551-6776-24-5-450-b23","series-title":"Nephrol Dial Transplant","first-page":"1517","article-title":"Large-pore haemodialysis membranes: an efficient tool for rapid removal of vancomycin after accidental overdose","volume":"20","year":"2005","unstructured":"Ulinski\n              T\n            , DeschenesG, BensmanA.\n          Large-pore haemodialysis membranes: an efficient tool for rapid removal of vancomycin after accidental overdose. Nephrol Dial Transplant. 2005;20(7):1517\u20131518."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/24\/5\/article-p450.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/24\/5\/450\/2466219\/1551-6776-24_5_450.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/24\/5\/article-p450.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/24\/5\/article-p450.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:41:23Z","timestamp":1747356083000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/24\/5\/article-p450.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":23,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-24.5.450","relation":{},"ISSN":["1551-6776"],"issn-type":[{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2019]]}}}